Parental Medication Education for Preventing Medication Errors After NICU Discharge
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests two methods to help parents manage their child's medication after discharge from the neonatal intensive care unit (NICU). The study aims to determine if HELPix or HELPix+Tech (medication management tools) can reduce medication errors by providing customized instructions and app support. Parents whose babies leave the NICU with a prescription for daily liquid medication (excluding vitamins) may be suitable candidates. Participants must speak English or Spanish and have access to a mobile device that can receive texts and connect to the internet. As an unphased trial, this study offers parents the chance to contribute to innovative solutions for medication management.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that HELPix and HELPix+Tech aim to make medication use safer and improve care coordination. Although specific safety data for HELPix is not yet available, studies have indicated that clear instructions, such as pictures, can reduce medication mistakes. This suggests HELPix could be safe by helping people understand and avoid errors.
For HELPix+Tech, research indicates that technology in healthcare can help prevent medication mistakes. This suggests HELPix+Tech might also be safe, as it uses tech tools to clarify medication instructions and prevent errors. Both treatments are designed to help parents manage their child's medications safely after hospital discharge.12345Why are researchers excited about this trial?
Researchers are excited about the trial involving HELPix and HELPix+Tech because these approaches aim to prevent medication errors after NICU discharge by enhancing parental education. Unlike standard care, which typically involves discharge counseling by nurses and possibly doctors, HELPix provides personalized, regimen-specific medication instruction sheets tailored to the needs of each family. The HELPix+Tech adds an innovative digital component, using an app to guide parents through medication management, making it easier for them to understand and follow instructions. This personalized and tech-supported approach could significantly improve medication safety and compliance compared to traditional methods.
What evidence suggests that this trial's treatments could be effective for preventing medication errors after NICU discharge?
Studies have shown that tools like HELPix, one of the interventions in this trial, can reduce medication mistakes in newborn care by 50–70%. This reduction is crucial because such errors can harm babies. Research also indicates that HELPix+Tech, another intervention in this trial that combines HELPix with an app, effectively reduces these mistakes. Over 90% of studies report fewer medication errors with these tools. The app aids parents in understanding and managing their baby's medicine, enhancing safety. This evidence suggests that both HELPix and HELPix+Tech could help prevent medication errors after a baby leaves the NICU.678910
Who Is on the Research Team?
Hsiang Sharon Yin
Principal Investigator
NYU Langone
Are You a Good Fit for This Trial?
This trial is for parents over 18, who speak English or Spanish, and are the primary caregivers administering at least one daily liquid medication to their child after discharge from the neonatal intensive care unit. Participants must have internet access, a mobile phone that can receive texts, and be able to return for follow-up visits.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Preparatory Phase
Preparatory activities for the study, including recruitment and initial setup
Intervention Phase
Parents receive usual care, HELPix, and/or HELPix+Tech interventions to support safe medication use
Follow-up
Participants are monitored for safety and effectiveness after intervention
What Are the Treatments Tested in This Trial?
Interventions
- HELPix
- HELPix+Tech
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor